Cresco Labs (CRLBF) Cash from Investing Activities Growth (1y) (2020 - 2026)
Cresco Labs (CRLBF) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Cresco Labs | 245.85 Mn | 182.28 Mn | 75.45 Mn | 181.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.33% |
| Dec 31, 2025 | -339.50% |
| Sep 30, 2025 | 2.31% |
| Dec 31, 2024 | -215.48% |
| Sep 30, 2024 | 49.75% |
| Dec 31, 2023 | 120.95% |
| Sep 30, 2023 | -153.13% |
| Dec 31, 2022 | 80.57% |
| Sep 30, 2022 | 168.04% |
| Dec 31, 2021 | -581.77% |
| Sep 30, 2021 | -36.15% |
| Mar 31, 2021 | 48.63% |
| Dec 31, 2020 | 56.66% |